Cell-Laden Composite Hydrogel Bioinks with Human Bone Allograft Particles to Enhance Stem Cell Osteogenesis.
Hadis GharachehMurat GuvendirenPublished in: Polymers (2022)
There is a growing demand for bone graft substitutes that mimic the extracellular matrix properties of the native bone tissue to enhance stem cell osteogenesis. Composite hydrogels containing human bone allograft particles are particularly interesting due to inherent bioactivity of the allograft tissue. Here, we report a novel photocurable composite hydrogel bioink for bone tissue engineering. Our composite bioink is formulated by incorporating human allograft bone particles in a methacrylated alginate formulation to enhance adult human mesenchymal stem cell (hMSC) osteogenesis. Detailed rheology and printability studies confirm suitability of our composite bioinks for extrusion-based 3D bioprinting technology. In vitro studies reveal high cell viability (~90%) for hMSCs up to 28 days of culture within 3D bioprinted composite scaffolds. When cultured within bioprinted composite scaffolds, hMSCs show significantly enhanced osteogenic differentiation as compared to neat scaffolds based on alkaline phosphatase activity, calcium deposition, and osteocalcin expression.
Keyphrases
- tissue engineering
- endothelial cells
- stem cells
- bone mineral density
- bone regeneration
- extracellular matrix
- drug delivery
- soft tissue
- mesenchymal stem cells
- induced pluripotent stem cells
- bone loss
- pluripotent stem cells
- kidney transplantation
- gene expression
- postmenopausal women
- body composition
- umbilical cord
- genome wide
- long non coding rna
- drug release